Mohammed I El-Gamal

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Structure Activity Relationship

Basal Cell Carcinoma

Top Venues

Archiv der Pharmazie

Antibiotics (Basel, Switzerland)

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Esra M Mustafa, Afnan I Shahin, Aishah S Alrashed, Aesheh H Bahaaddin, Aljawhra A Alajmi, Omar Hashem, Hanan S Anbar, Mohammed I El-Gamal
An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020-2024). Archiv der Pharmazie (2024)
Afnan I Shahin, Seyed-Omar Zaraei, Shahed Alzuraiqi, Zahaa Abdulateef, Noora E Abbas, Taleb H Al-Tel, Mohammed I El-Gamal
Evaluation of 2,3-dihydroimidazo[2,1- b ]oxazole and imidazo[2,1- b ]oxazole derivatives as chemotherapeutic agents. Future medicinal chemistry (2023)
Afnan I Shahin, Sumera Zaib, Seyed-Omar Zaraei, Reena A Kedia, Hanan S Anbar, Muhammad Tayyab Younas, Taleb H Al-Tel, Ghalia Khoder, Mohammed I El-Gamal
Design and synthesis of novel anti-urease imidazothiazole derivatives with promising antibacterial activity against Helicobacter pylori. PloS one 18 (6) (2023)
Noor Akbar, Mohammed I El-Gamal, Balsam Qubais Saeed, Chang-Hyun Oh, Mohammed S Abdel-Maksoud, Naveed Ahmad Khan, Ahmad M Alharbi, Hasan Alfahemi, Ruqaiyyah Siddiqui
Antiamoebic Activity of Imidazothiazole Derivatives against Opportunistic Pathogen Acanthamoeba castellanii . Antibiotics (Basel, Switzerland) 11 (9) (2022)
Mohammed I El-Gamal, Seyed-Omar Zaraei, Moustafa M Madkour, Hanan S Anbar
Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011-2020): Current Status and Future Prospects. Molecules (Basel, Switzerland) 27 (1) (2022)
Dana M Zaher, Mohammed I El-Gamal, Hany A Omar, Sarah N Aljareh, Salma A Al-Shamma, Aya J Ali, Sumera Zaib, Jamshed Iqbal
Recent advances with alkaline phosphatase isoenzymes and their inhibitors. Archiv der Pharmazie 353 (5) (2020)